IMM 13.2% 29.5¢ immutep limited

Ann: Immutep completes institutional pro-rata offer & placement, page-23

  1. 886 Posts.
    lightbulb Created with Sketch. 391
    $100M of Keytruda is less than half a percent of annual sales of Keytruda.

    How are they paying this amount when a cap raise was just done? Shareholders are paying for it. They aren’t paying $100M out of their own pocket. They are just foregoing the profit margin on $100M worth of Keytruda.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.